Delonix elata L.is a Ceasalpinaceae species and is traditionally used in India for treatment of skin diseases,liver diseases and rheumatic problems.However,systematic evaluation of its wound healing activity is lackin...Delonix elata L.is a Ceasalpinaceae species and is traditionally used in India for treatment of skin diseases,liver diseases and rheumatic problems.However,systematic evaluation of its wound healing activity is lacking.Thus,in the present study,we aimed to assess the wound healing activity of D.elata stem bark extract(DSE) and its isolated constituent quercetin-3-rhamnopyranosyl-(1-6) glucopyranoside(QRPG) in rats.The formulations effects on wound healing were assessed by the wound contraction rate,epithelialization period,tensile strength,content of the hydroxyproline,hexosamine and uronic acid in granulation tissue,histopathological studies and Col 1 α(I) expression level in wound tissue by reverse transcription polymerase chain reaction(RT-PCR) study.The topical application of DSE ointment caused faster epithelialization,significant wound contraction(100%),and better tensile strength(710.5 ± 10.5 g/cm^2),while QRPG showed wound epithelialization with 98.2%contraction,better than that of the control group(78.18%).The biochemical analysis of granulation tissue revealed that DSE and QRPG significantly increased hydroxyproline,hexosamine and uronic acid content.A significant increase in the expression of Col 1 α(I) was observed in the wound tissue of DSE and QRPG treated rats.DSE and QRPG were shown to enhance wound healing by increasing collagen synthesis through upregulation of Col 1 α(I),thus validating ethnomedicinal uses.展开更多
目的探讨冠心宁片对气滞血瘀证冠心病伴轻度高血压病患者血清C1q/肿瘤坏死因子相关蛋白3(CTRP3)、脂蛋白相关磷脂酶A2(Lp-PLA2)、半乳糖凝聚素-3(Gal-3)水平的影响。方法收集气滞血瘀证冠心病伴轻度高血压病患者84例,按照随机数字表法...目的探讨冠心宁片对气滞血瘀证冠心病伴轻度高血压病患者血清C1q/肿瘤坏死因子相关蛋白3(CTRP3)、脂蛋白相关磷脂酶A2(Lp-PLA2)、半乳糖凝聚素-3(Gal-3)水平的影响。方法收集气滞血瘀证冠心病伴轻度高血压病患者84例,按照随机数字表法分为治疗组和对照组,每组42例。对照组给予曲美他嗪治疗,治疗组患者在对照组的基础上联合冠心宁治疗,两组连续观察3个月。比较两组心功能指标、24 h动态血压、气滞血瘀证评分以及血清CTRP3、Lp-PLA2、Gal-3水平。结果治疗后,治疗组的左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)均低于对照组,左室射血分数(LVEF)以及舒张早期/舒张晚期最大血流速度(E/A)均高于对照组,差异均有统计学意义(t分别=3.96、4.99、-5.04、-5.38,P均<0.05);治疗组的24 h收缩压(24 h SBP)与24 h舒张压(24 h DBP)均低于对照组(t分别=3.34、1.74,P均<0.05);治疗组的气滞血瘀证评分低于对照组(t=7.50,P<0.05);治疗组的CTRP3水平高于对照组,Lp-PLA2、Gal-3水平低于对照组,差异均有统计学意义(t分别=-6.00、2.84、8.80,P均<0.05)。结论冠心宁片对气滞血瘀证冠心病伴轻度高血压病患者的疗效显著,可调节血清CTRP3、Lp-PLA2、Gal-3水平,改善其疗效。展开更多
基金partially supported by the Department of Biotechnology,New Delhi,India(Grant no.BT/PR11505/SPD/24/337/2008BT/PR9128/INF/22/190/2013)
文摘Delonix elata L.is a Ceasalpinaceae species and is traditionally used in India for treatment of skin diseases,liver diseases and rheumatic problems.However,systematic evaluation of its wound healing activity is lacking.Thus,in the present study,we aimed to assess the wound healing activity of D.elata stem bark extract(DSE) and its isolated constituent quercetin-3-rhamnopyranosyl-(1-6) glucopyranoside(QRPG) in rats.The formulations effects on wound healing were assessed by the wound contraction rate,epithelialization period,tensile strength,content of the hydroxyproline,hexosamine and uronic acid in granulation tissue,histopathological studies and Col 1 α(I) expression level in wound tissue by reverse transcription polymerase chain reaction(RT-PCR) study.The topical application of DSE ointment caused faster epithelialization,significant wound contraction(100%),and better tensile strength(710.5 ± 10.5 g/cm^2),while QRPG showed wound epithelialization with 98.2%contraction,better than that of the control group(78.18%).The biochemical analysis of granulation tissue revealed that DSE and QRPG significantly increased hydroxyproline,hexosamine and uronic acid content.A significant increase in the expression of Col 1 α(I) was observed in the wound tissue of DSE and QRPG treated rats.DSE and QRPG were shown to enhance wound healing by increasing collagen synthesis through upregulation of Col 1 α(I),thus validating ethnomedicinal uses.
文摘目的探讨冠心宁片对气滞血瘀证冠心病伴轻度高血压病患者血清C1q/肿瘤坏死因子相关蛋白3(CTRP3)、脂蛋白相关磷脂酶A2(Lp-PLA2)、半乳糖凝聚素-3(Gal-3)水平的影响。方法收集气滞血瘀证冠心病伴轻度高血压病患者84例,按照随机数字表法分为治疗组和对照组,每组42例。对照组给予曲美他嗪治疗,治疗组患者在对照组的基础上联合冠心宁治疗,两组连续观察3个月。比较两组心功能指标、24 h动态血压、气滞血瘀证评分以及血清CTRP3、Lp-PLA2、Gal-3水平。结果治疗后,治疗组的左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)均低于对照组,左室射血分数(LVEF)以及舒张早期/舒张晚期最大血流速度(E/A)均高于对照组,差异均有统计学意义(t分别=3.96、4.99、-5.04、-5.38,P均<0.05);治疗组的24 h收缩压(24 h SBP)与24 h舒张压(24 h DBP)均低于对照组(t分别=3.34、1.74,P均<0.05);治疗组的气滞血瘀证评分低于对照组(t=7.50,P<0.05);治疗组的CTRP3水平高于对照组,Lp-PLA2、Gal-3水平低于对照组,差异均有统计学意义(t分别=-6.00、2.84、8.80,P均<0.05)。结论冠心宁片对气滞血瘀证冠心病伴轻度高血压病患者的疗效显著,可调节血清CTRP3、Lp-PLA2、Gal-3水平,改善其疗效。